Huang Xiaosong, Lott Paul C, Hu Donglei, Zavala Valentina A, Jamal Zoeb N, Vidaurre Tatiana, Casavilca-Zambrano Sandro, Navarro Vásquez Jeannie, Castañeda Carlos A, Valencia Guillermo, Morante Zaida, Calderón Mónica, Abugattas Julio E, Fuentes Hugo A, Liendo-Picoaga Ruddy, Cotrina Jose M, Neciosup Silvia P, Rioja Viera Patricia, Salinas Luis A, Galvez-Nino Marco, Huntsman Scott, Sanchez Sixto E, Williams Michelle A, Gelaye Bizu, Estrada-Florez Ana P, Polanco-Echeverry Guadalupe, Echeverry Magdalena, Velez Alejandro, Carmona-Valencia Jenny A, Bohorquez-Lozano Mabel E, Torres Javier, Cruz Miguel, Ho Weang-Kee, Teo Soo Hwang, Tai Mei Chee, John Esther M, Haiman Christopher A, Conti David V, Chen Fei, Torres-Mejía Gabriela, Kushi Lawrence H, Neuhausen Susan L, Ziv Elad, Carvajal-Carmona Luis G, Fejerman Laura
Department of Public Health Sciences, University of California Davis, Davis, California.
Genome Center, University of California Davis, Davis, California.
Cancer Epidemiol Biomarkers Prev. 2025 Feb 6;34(2):234-245. doi: 10.1158/1055-9965.EPI-24-1247.
A substantial portion of the genetic predisposition for breast cancer is explained by multiple common genetic variants of relatively small effect. A subset of these variants, which have been identified mostly in individuals of European (EUR) and Asian ancestries, have been combined to construct a polygenic risk score (PRS) to predict breast cancer risk, but the prediction accuracy of existing PRSs in Hispanic/Latinx individuals (H/L) remain relatively low. We assessed the performance of several existing PRS panels with and without addition of H/L-specific variants among self-reported H/L women.
PRS performance was evaluated using multivariable logistic regression and the area under the ROC curve.
Both EUR and Asian PRSs performed worse in H/L samples compared with original reports. The best EUR PRS performed better than the best Asian PRS in pooled H/L samples. EUR PRSs had decreased performance with increasing Indigenous American (IA) ancestry, while Asian PRSs had increased performance with increasing IA ancestry. The addition of two H/L SNPs increased performance for all PRSs, most notably in the samples with high IA ancestry, and did not impact the performance of PRSs in individuals with lower IA ancestry.
A single PRS that incorporates risk variants relevant to the multiple ancestral components of individuals from Latin America, instead of a set of ancestry-specific panels, could be used in clinical practice.
The results highlight the importance of population-specific discovery and suggest a straightforward approach to integrate ancestry-specific variants into PRSs for clinical application.
乳腺癌的大部分遗传易感性可由多个效应相对较小的常见基因变异来解释。这些变异中的一部分,大多是在欧洲(EUR)和亚洲血统个体中发现的,已被组合构建多基因风险评分(PRS)以预测乳腺癌风险,但现有PRS在西班牙裔/拉丁裔个体(H/L)中的预测准确性仍然相对较低。我们评估了几个现有PRS面板在自我报告的H/L女性中添加和不添加H/L特异性变异时的性能。
使用多变量逻辑回归和ROC曲线下面积评估PRS性能。
与原始报告相比,EUR和亚洲PRS在H/L样本中的表现均较差。在汇总的H/L样本中,最佳EUR PRS的表现优于最佳亚洲PRS。EUR PRS的性能随着美洲原住民(IA)血统的增加而下降,而亚洲PRS的性能随着IA血统的增加而提高。添加两个H/L单核苷酸多态性(SNP)可提高所有PRS的性能,在IA血统高的样本中最为显著,并且不会影响IA血统较低个体中PRS的性能。
在临床实践中可以使用一个包含与拉丁美洲个体多个祖先成分相关风险变异的单一PRS,而不是一组特定血统的面板。
结果突出了特定人群发现的重要性,并提出了一种将特定血统变异整合到PRS中用于临床应用的直接方法。